This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Aug 1;4(4):467-8.

doi: 10.1161/CIRCGENETICS.111.960955.

Lack of association of KIF6 genotype with vascular disease and statin response

Kiran Musunuru¹

Affiliations

PMID: 21846872
DOI: 10.1161/CIRCGENETICS.111.960955

Comment

Lack of association of KIF6 genotype with vascular disease and statin response

Kiran Musunuru. Circ Cardiovasc Genet. 2011.

. 2011 Aug 1;4(4):467-8.

doi: 10.1161/CIRCGENETICS.111.960955.

Author

Kiran Musunuru¹

Affiliation

¹ Massachusetts General Hospital, Boston, MA 02114, USA. kiranmusunuru@gmail.com

PMID: 21846872
DOI: 10.1161/CIRCGENETICS.111.960955

No abstract available

PubMed Disclaimer

Comment on

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
Hopewell JC, Parish S, Clarke R, Armitage J, Bowman L, Hager J, Lathrop M, Collins R; MRC/BHF Heart Protection Study Collaborative Group. Hopewell JC, et al. J Am Coll Cardiol. 2011 May 17;57(20):2000-7. doi: 10.1016/j.jacc.2011.02.015. Epub 2011 Mar 31. J Am Coll Cardiol. 2011. PMID: 21458191 Clinical Trial.
Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.
Ridker PM, MacFadyen JG, Glynn RJ, Chasman DI. Ridker PM, et al. Circ Cardiovasc Genet. 2011 Jun;4(3):312-7. doi: 10.1161/CIRCGENETICS.110.959353. Epub 2011 Apr 14. Circ Cardiovasc Genet. 2011. PMID: 21493817

Similar articles

Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study.
de Keyser CE, Eijgelsheim M, Hofman A, Sijbrands EJ, Maitland-van der Zee AH, van Duijn CM, Uitterlinden AG, Witteman JC, Ch Stricker BH. de Keyser CE, et al. Pharmacogenomics J. 2011 Feb;11(1):72-80. doi: 10.1038/tpj.2010.11. Epub 2010 Mar 2. Pharmacogenomics J. 2011. PMID: 20195290
Statin use and the risk of Alzheimer's disease: the MIRAGE study.
Green RC, McNagny SE, Jayakumar P, Cupples LA, Benke K, Farrer LA; MIRAGE Study Group. Green RC, et al. Alzheimers Dement. 2006 Apr;2(2):96-103. doi: 10.1016/j.jalz.2006.02.003. Alzheimers Dement. 2006. PMID: 19595865
Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
Donnelly LA, Palmer CN, Whitley AL, Lang CC, Doney AS, Morris AD, Donnan PT. Donnelly LA, et al. Pharmacogenet Genomics. 2008 Apr;18(4):279-87. doi: 10.1097/FPC.0b013e3282f60aad. Pharmacogenet Genomics. 2008. PMID: 18334912
Pharmacogenomics of statin response.
Mangravite LM, Krauss RM. Mangravite LM, et al. Curr Opin Lipidol. 2007 Aug;18(4):409-14. doi: 10.1097/MOL.0b013e328235a5a2. Curr Opin Lipidol. 2007. PMID: 17620857 Review.
Statins: are any questions unanswered?
Kearney PM, Baigent C. Kearney PM, et al. Curr Opin Lipidol. 2006 Aug;17(4):418-25. doi: 10.1097/01.mol.0000236368.42755.25. Curr Opin Lipidol. 2006. PMID: 16832166 Review.

See all similar articles

Cited by

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment.
Ruiz-Iruela C, Padró-Miquel A, Pintó-Sala X, Baena-Díez N, Caixàs-Pedragós A, Güell-Miró R, Navarro-Badal R, Jusmet-Miguel X, Calmarza P, Puzo-Foncilla JL, Alía-Ramos P, Candás-Estébanez B. Ruiz-Iruela C, et al. PLoS One. 2018 Oct 10;13(10):e0205430. doi: 10.1371/journal.pone.0205430. eCollection 2018. PLoS One. 2018. PMID: 30304062 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database